These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease. Bennett D Int J Clin Pract Suppl; 2001 May; (120):41-8. PubMed ID: 11406925 [TBL] [Abstract][Full Text] [Related]
28. Vascular characteristics of patients with dementia. Morović S; Jurasić MJ; Martinić Popović I; Serić V; Lisak M; Demarin V J Neurol Sci; 2009 Aug; 283(1-2):41-3. PubMed ID: 19375085 [TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Ballard C; Sauter M; Scheltens P; He Y; Barkhof F; van Straaten EC; van der Flier WM; Hsu C; Wu S; Lane R Curr Med Res Opin; 2008 Sep; 24(9):2561-74. PubMed ID: 18674411 [TBL] [Abstract][Full Text] [Related]
32. Dementia with cerebrovascular disease: the benefits of early treatment. Schindler RJ Eur J Neurol; 2005 Oct; 12 Suppl 3():17-21. PubMed ID: 16144533 [TBL] [Abstract][Full Text] [Related]
33. Donepezil for dementia due to Alzheimer's disease. Birks JS; Harvey RJ Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184 [TBL] [Abstract][Full Text] [Related]
34. Neuroprotection in vascular dementia. Martínez-Vila E; Murie-Fernández M; Gállego Pérez-Larraya J; Irimia P Cerebrovasc Dis; 2006; 21 Suppl 2():106-17. PubMed ID: 16651821 [TBL] [Abstract][Full Text] [Related]